The Oral Cancer Treatment Market continues to expand with ongoing advancements in chemotherapy and radiation therapy. These conventional therapies remain essential in oral cancer management, particularly in cases where surgery is not feasible.

Chemotherapy uses cytotoxic drugs to destroy rapidly dividing cancer cells, while radiation therapy targets tumors with high-energy rays to shrink them and prevent recurrence. Recent innovations in drug delivery and precision radiotherapy have improved treatment efficacy and reduced side effects.

Combination therapies, integrating chemotherapy, radiation, and targeted therapies, are becoming increasingly common. Multimodal approaches enhance overall survival and treatment effectiveness. Hospitals are also emphasizing supportive care, including nutrition and pain management, to improve patient quality of life.

FAQs
Q1. What are chemotherapy and radiation therapy in oral cancer?
Chemotherapy uses drugs, and radiation therapy uses high-energy rays to target cancer.

Q2. Benefits of combination therapy?
Improved survival rates and treatment effectiveness.

Q3. What drives market growth?
Technological advancements, multimodal approaches, and rising prevalence of oral cancer.

GLOBAL SUPPLY CHAIN DISRUPTION ALERT
Delays in chemotherapy drugs and radiation equipment due to logistics and geopolitical factors may impact treatment schedules.
👉 Request a Sample Report for real-time market impact analysis, price outlooks, and alternative sourcing strategies.